series-a
Stage
2
Investors
About
Predicta Biosciences develops a molecular insights platform that uses whole-genome sequencing and immune profiling from blood or bone marrow samples to characterize blood cancers, supporting diagnostics, treatment decisions, and disease monitoring.
Explore Predicta Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.